Read our New Blog Post  -  The Multitude of Glycoforms

Our Products

venn-vista-graph-1

VENN Vista

Glycoproteomic Analysis by LC-MS and AI/ML
venn-vista-graph-1

InterVenn’s AI-enabled, mass spectrometry glycoproteomics platform enables researchers at academic centers and biopharmaceutical companies to assess post-translational modifications at an unprecedented scale and speed. This empowers them to study biology and enhance drug development efforts using an -omic dimension that more closely recapitulates the disease phenotype.

Venn Vista is the first commercially available panel capable of assessing blood (serum or plasma) protein glycosylation in a site-specific manner, across more than 500 peptides and glycopeptides.

Key features:

  • Quantification of more than 500 glycoproteoforms in a single measurement. Protein list available upon request
  • Dynamic range: 4 orders of magnitude
  • High throughput analysis, suitable for large cohort studies
  • Sample requirement: 10 microliters of serum/plasma

Site-specific measurement of protein glycoforms provides unique insight into protein functionality that traditional immunoassays or aptamer-based approaches cannot.

Key features:

  • Quantification of more than 500 glycoproteoforms in a single measurement. Protein list available upon request
  • Dynamic range: 4 orders of magnitude
  • High throughput analysis, suitable for large cohort studies
  • Sample requirement: 10 microliters of serum/plasma

Site-specific measurement of protein glycoforms provides unique insight into protein functionality that traditional immunoassays or aptamer-based approaches cannot.

Illuminate Your Research with VENN Vista

Using the proprietary Venn Vista workflow, we and our partners around the world have discovered clinically actionable biomarkers for disease diagnosis, prognosis and recurrence detection, as well as panels for patient stratification, treatment prediction and monitoring. Use cases span across various areas in oncology, autoimmunity, metabolism and neurology.

Hey! Just letting you know we use cookies. We use cookies to improve your browsing experience. By continuing to browse this site, you agree to our privacy policy and use of cookies.